11-gauge needle better than 14-gauge in breast biopsy

Feb 02, 2009

Stereotactic vacuum-assisted breast needle biopsy, a common minimally invasive biopsy method used in the US, is more effective with an 11-gauge needle than the 14-gauge needle decreasing a physician's chances of false-negative diagnoses, according to a study performed at the Stanford University School of Medicine in Stanford, CA.

The study included 1,280 breast lesions that were consecutively biopsied using a 14-gauge or 11-gauge vacuum needle. Results showed that cancer was missed in 3/68 cases (4.5%) using the 14-gauge needle and in only 2/440 (0.45%) cases using the 11-gauge needle. "The 11 gauge is more accurate than the 14," said Roger Jackman, MD, lead author of the study.

"Specimens obtained with both needles are the same length, but those with the 11-gauge needle are larger in diameter and volume which presumably leads to the better results with the 11-gauge needle. Most women say the procedure is very tolerable with less discomfort than a trip to the dentist for a filling. I feel there is much more concern waiting for the results of the biopsy rather than the procedure itself," said Dr. Jackman. "Any woman undergoing a biopsy and physician performing a biopsy wants safety and accuracy. Accuracy is absolutely critical," he said.

"This procedure is the most accurate way to biopsy an abnormality found on a mammogram. It is one that is safer and less expensive than surgical biopsy. The triple headed win of accuracy, safety and cost savings is extremely exciting and important," said Dr. Jackman.

This study appears in the February issue of the American Journal of Roentgenology.

Source: American Roentgen Ray Society

Explore further: Endogenous hormones improve breast cancer risk models

add to favorites email to friend print save as pdf

Related Stories

New technique identifies cellular 'needle in a haystack'

Jul 12, 2012

Rare cells can be identified within mixed cell populations with near perfect accuracy using a detection technique devised by research teams led by Robert Wieder, MD, PhD, at the University of Medicine and Dentistry of New ...

Recommended for you

Endogenous hormones improve breast cancer risk models

21 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

22 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments : 0